---
title: "ABH Healthcare Ltd (ABH) — Share Price, Financials & Analysis"
symbol: "ABH"
company: "ABH Healthcare Ltd"
canonical: "https://tapetide.com/stocks/ABH"
isin: "INE1R2M01019"
nse_symbol: "ABH"
sector: "Healthcare"
industry: "Healthcare Services"
market_cap_cr: 71.66
generated_at: "2026-09-13T18:57:40.306Z"
---

# ABH Healthcare Ltd (ABH)

Canonical page: https://tapetide.com/stocks/ABH

## Company

- **NSE Symbol:** ABH
- **ISIN:** INE1R2M01019
- **Sector:** Healthcare
- **Industry:** Healthcare Services
- **Macro Sector:** Healthcare
- **Listed Since:** 2026-09-01
- **Face Value:** ₹10
- **F&O Eligible:** No

## About

ABH Healthcare Ltd provides healthcare 
services and operates under the name 
Anil Baghi Hospital[1]

## Latest Price

- **Price:** ₹62.7
- **Change:** -3.25 (-4.93%)
- **Open:** ₹62.7
- **Day High:** ₹62.7
- **Day Low:** ₹62.7
- **Previous Close:** ₹65.95
- **Volume:** 43200
- **As Of:** 2026-09-11T09:46:43+00:00

## Key Fundamentals

Observed at 2026-09-11T04:33:26.203671Z.

- **Market Cap:** ₹71.66 Cr
- **Classification:** SME
- **P/E (reported):** 13.4
- **Book Value:** ₹45.78
- **Price to Book:** 1.44
- **Dividend Yield:** 0%
- **ROE:** 32.52%
- **ROCE:** 17.45%
- **Debt to Equity:** 3.17
- **Revenue (yearly):** ₹52.6 Cr
- **Net Income:** ₹5.6 Cr
- **EBITDA:** ₹14.8 Cr
- **52-Week High:** ₹102
- **52-Week Low:** ₹65.85

## Key Insights

### Strengths

- Company has a good return on equity (ROE) track record: 3 Years ROE 45.5%

### Weaknesses

- Company has high debtors of 234 days.
- Working capital days have increased from 64.0 days to 172 days

## Growth Rates

| Metric | 1Y | 3Y | 5Y |
| --- | --- | --- | --- |
| ebitda margin growth | 4.77% | 68.6% | 313.22% |
| net income growth | 5.66% | 100% | — |
| revenue growth | 6.69% | 21% | 71.94% |
| roce | -33.04% | 9.47% | 14.75% |
| roe | -28.84% | 34.76% | -29.23% |

## Financial Statements

### Profit & Loss

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- |
| Sales | 3.5 | 29.19 | 39.93 | 48.55 | 51.6 |
| Expenses | 3.27 | 25.12 | 32.29 | 35.36 | 36.76 |
| Operating Profit | 0.23 | 4.07 | 7.64 | 13.19 | 14.84 |
| OPM % | 6.57 | 13.94 | 19.13 | 27.17 | 28.76 |
| Other Income | 0 | -0.02 | -0.73 | 0.05 | -0.04 |
| Interest | 0.04 | 1.33 | 2.96 | 3.71 | 4.48 |
| Depreciation | 0.07 | 1.56 | 1.74 | 2.1 | 2.39 |
| Profit before tax | 0.12 | 1.16 | 2.21 | 7.43 | 7.93 |
| Tax % | 33.33 | 37.93 | 24.89 | 27.99 | 28.88 |
| Net Profit | 0.09 | 0.71 | 1.66 | 5.35 | 5.64 |
| EPS in Rs | 9 | 3.55 | 8.3 | 26.7 | 7.06 |
| Dividend Payout % | 0 | 0 | 0 | 0 | 0 |

### Balance Sheet

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- |
| Equity Capital | 0.1 | 2 | 2 | 2 | 8 |
| Reserves | 0.09 | 2.7 | 4.35 | 9.69 | 9.34 |
| Borrowings | 20.62 | 20.97 | 35.79 | 41.88 | 55.03 |
| Other Liabilities | 5.46 | 7.29 | 9.2 | 10.33 | 12.9 |
| Total Liabilities | 26.27 | 32.96 | 51.34 | 63.9 | 85.27 |
| Fixed Assets | 23.48 | 22.73 | 33.81 | 36.68 | 41.92 |
| CWIP | 0 | 0.63 | 0 | 0 | 0 |
| Investments | 0 | 0 | 0.12 | 0.29 | 1.74 |
| Other Assets | 2.79 | 9.6 | 17.41 | 26.93 | 41.61 |
| Total Assets | 26.27 | 32.96 | 51.34 | 63.9 | 85.27 |

### Cash Flow

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- |
| Cash from Operating Activity | 3.06 | -1.55 | 0.89 | 3.54 | 2.11 |
| Cash from Investing Activity | -23.55 | -1.45 | -13.06 | -4.53 | -9.14 |
| Cash from Financing Activity | 20.7 | 2.94 | 12.04 | 1.58 | 9.45 |
| Net Cash Flow | 0.22 | -0.06 | -0.14 | 0.59 | 2.42 |
| Free Cash Flow | -20.49 | -3 | -12.05 | -1.11 | -5.64 |
| CFO/OP | 1330 | -17 | 26 | 31 | 24 |

### Ratios

| Item | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- |
| Debtor Days | 23.99 | 73.65 | 109.51 | 148.41 | 234.21 |
| Inventory Days | — | — | — | 158.97 | 117.45 |
| Days Payable | — | — | — | 241.67 | 238.51 |
| Cash Conversion Cycle | 23.99 | 73.65 | 109.51 | 65.71 | 113.14 |
| Working Capital Days | -985.5 | -59.4 | -16.91 | 36.46 | 172.38 |
| ROCE % | — | 10.8 | 17.43 | 23.28 | 19.9 |

## Shareholding Pattern

### Quarterly

| Category | Jun 2025 |
| --- | --- |
| Promoters | 100% |
| FIIs | 0% |
| DIIs | 0% |
| Government | 0% |
| Public | 0% |
| Others | 0% |
| No. of Shareholders | 7 |

## Technical Indicators

Derived from daily closing prices and recomputed each trading session; values move with the market.

- **Overall Signal:** Neutral
- **Buy / Neutral / Sell:** 0 / 19 / 0

### Moving Averages — summary: **Neutral**

| Indicator | Value | Signal |
| --- | --- | --- |
| SMA (10) | — | Neutral |
| EMA (10) | — | Neutral |
| SMA (20) | — | Neutral |
| EMA (20) | — | Neutral |
| SMA (50) | — | Neutral |
| EMA (50) | — | Neutral |
| SMA (100) | — | Neutral |
| EMA (100) | — | Neutral |
| SMA (200) | — | Neutral |
| EMA (200) | — | Neutral |

### Oscillators — summary: **Neutral**

| Indicator | Value | Signal |
| --- | --- | --- |
| RSI (14) | — | Neutral |
| MACD (12,26,9) | — | Neutral |
| Stochastic (14,3,3) | — | Neutral |
| ADX (14) | — | Neutral |
| Williams %R (14) | — | Neutral |
| ATR (14) | — | Neutral |
| ROC (12) | — | Neutral |
| Stoch RSI (14) | — | Neutral |
| UO (7,14,28) | — | Neutral |

---

Provenance differs by section. Financial statements, shareholding and filings are as reported in company disclosures to NSE/BSE/SEBI. Price, volume and 52-week levels are exchange market data. Technical indicators are computed by Tapetide from daily closing prices. The Tapetide Score is Tapetide's own analysis. Analyst ratings are third-party estimates, not company statements. All figures are for research and information only and are not investment advice. Generated 2026-09-13T18:57:40.306Z.